Long term outcomes of genome edited 'universal' CAR19 T-cells for relapsed/refractory B-ALL at a single pediatric centre

Guardo, Daniela; Mishra, Avijeet Kumar; Rashed, Hebatalla; Gilmour, Kimberly C; Adams, Stuart P; Pinner, Danielle; Sauer, Martin G.; Vora, Ajay; Veys, Paul; Pavasovic, Vesna; Rao, Kanchan; Qasim, Waseem

doi:10.1182/bloodadvances.2025016366

This content is only available as a PDF.

2025

Licensed under Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0), permitting only noncommercial, nonderivative use with attribution. All other rights reserved.

Long term outcomes of genome edited 'universal' CAR19 T-cells for relapsed/refractory B-ALL at a single pediatric centre

Article PDF first page preview

Supplemental data

Cited By

Email alerts

ASH Publications

American Society of Hematology

Long term outcomes of genome edited 'universal' CAR19 T-cells for relapsed/refractory B-ALL at a single pediatric centre Open Access

Article PDF first page preview

Supplemental data

Cited By

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only

Long term outcomes of genome edited 'universal' CAR19 T-cells for relapsed/refractory B-ALL at a single pediatric centre